Prenumeration
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
Pharma Equity Group (“PEG” or “the Company”) announced on Wednesday, December the 10th 2025, that the Company has entered into a Letter of Intent (LOI) to acquire either the entire share capital or a majority stake in the Danish MedTech company Otiom A/S (“Otiom”). The transaction represents the first concrete step in executing the Company’s expanded strategy: to build a diversified Life Science portfolio spanning Pharma, MedTech, and related health technologies.
Read Analyst Group’s comment here
About Analyst Group: One of Sweden's leading equity research boutiques with focus on small and medium-sized listed companies.
Read more about Analyst Group
This is a press release from Analyst Group regarding the publication of a comment on Pharma Equity Group. Readers may assume that Analyst Group has received compensation for making the comment. The Company has not been given an opportunity to influence the parts where Analyst Group has had opinions about the Company, future valuation or anything else that could be considered a subjective assessment.